-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Emmaus Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Emmaus Life Sciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $821K, a 3321% increase year-over-year.
- Emmaus Life Sciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $18K, a 97.7% decline year-over-year.
- Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2023 was $3.54M.
- Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2022 was -$6.59M, a 7.47% decline from 2021.
- Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2021 was -$6.13M, a 19050% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)